Medical - Distribution
Compare Stocks
5 / 10Stock Comparison
PBH vs ENR vs SPB vs CHD vs PG
Revenue, margins, valuation, and 5-year total return — side by side.
Electrical Equipment & Parts
Household & Personal Products
Household & Personal Products
Household & Personal Products
PBH vs ENR vs SPB vs CHD vs PG — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Medical - Distribution | Electrical Equipment & Parts | Household & Personal Products | Household & Personal Products | Household & Personal Products |
| Market Cap | $2.58B | $1.27B | $1.83B | $22.24B | $341.30B |
| Revenue (TTM) | $1.10B | $2.98B | $2.79B | $6.21B | $86.72B |
| Net Income (TTM) | $187M | $195M | $105M | $733M | $12.72B |
| Gross Margin | 56.4% | 40.9% | 36.6% | 45.1% | 50.3% |
| Operating Margin | 29.2% | 15.8% | 4.1% | 17.3% | 23.2% |
| Forward P/E | 12.0x | 5.6x | 14.8x | 25.0x | 21.1x |
| Total Debt | $1.04B | $3.53B | $654M | $2.21B | $35.46B |
| Cash & Equiv. | $98M | $236M | $124M | $409M | $9.56B |
PBH vs ENR vs SPB vs CHD vs PG — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Prestige Consumer H… (PBH) | 100 | 129.4 | +29.4% |
| Energizer Holdings,… (ENR) | 100 | 42.3 | -57.7% |
| Spectrum Brands Hol… (SPB) | 100 | 166.1 | +66.1% |
| Church & Dwight Co.… (CHD) | 100 | 125.1 | +25.1% |
| The Procter & Gambl… (PG) | 100 | 126.0 | +26.0% |
Price return only. Dividends and distributions are not included.
Quick Verdict: PBH vs ENR vs SPB vs CHD vs PG
Each card shows where this stock fits in a portfolio — not just who wins on paper.
PBH ranks third and is worth considering specifically for sleep-well-at-night.
- Lower volatility, beta 0.53, Low D/E 56.9%, current ratio 4.20x
- 16.9% margin vs SPB's 3.8%
ENR carries the broadest edge in this set and is the clearest fit for growth exposure and valuation efficiency.
- Rev growth 2.3%, EPS growth 5.4%, 3Y rev CAGR -1.1%
- PEG 0.15 vs PG's 3.78
- 2.3% revenue growth vs SPB's -5.2%
- Lower P/E (5.6x vs 21.1x), PEG 0.15 vs 3.78
SPB is the clearest fit if your priority is momentum.
- +30.1% vs PBH's -32.9%
Among these 5 stocks, CHD doesn't own a clear edge in any measured category.
PG is the #2 pick in this set and the best alternative if income & stability and long-term compounding is your priority.
- Dividend streak 36 yrs, beta 0.10, yield 2.8%
- 119.3% 10Y total return vs CHD's 113.6%
- Beta 0.10, yield 2.8%, current ratio 0.70x
- Beta 0.10 vs ENR's 1.24, lower leverage
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 2.3% revenue growth vs SPB's -5.2% | |
| Value | Lower P/E (5.6x vs 21.1x), PEG 0.15 vs 3.78 | |
| Quality / Margins | 16.9% margin vs SPB's 3.8% | |
| Stability / Safety | Beta 0.10 vs ENR's 1.24, lower leverage | |
| Dividends | 6.5% yield, 2-year raise streak, vs PG's 2.8%, (1 stock pays no dividend) | |
| Momentum (1Y) | +30.1% vs PBH's -32.9% | |
| Efficiency (ROA) | 10.0% ROA vs SPB's 3.0%, ROIC 20.1% vs 3.9% |
PBH vs ENR vs SPB vs CHD vs PG — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
PBH vs ENR vs SPB vs CHD vs PG — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
PBH leads in 1 of 6 categories
ENR leads 1 • PG leads 1 • SPB leads 1 • CHD leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
PBH leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
PG is the larger business by revenue, generating $86.7B annually — 78.6x PBH's $1.1B. PBH is the more profitable business, keeping 16.9% of every revenue dollar as net income compared to SPB's 3.8%. On growth, PG holds the edge at +7.4% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $1.1B | $3.0B | $2.8B | $6.2B | $86.7B |
| EBITDAEarnings before interest/tax | $353M | $566M | $214M | $1.3B | $21.9B |
| Net IncomeAfter-tax profit | $187M | $195M | $105M | $733M | $12.7B |
| Free Cash FlowCash after capex | $267M | $159M | $303M | $1.1B | $15.0B |
| Gross MarginGross profit ÷ Revenue | +56.4% | +40.9% | +36.6% | +45.1% | +50.3% |
| Operating MarginEBIT ÷ Revenue | +29.2% | +15.8% | +4.1% | +17.3% | +23.2% |
| Net MarginNet income ÷ Revenue | +16.9% | +6.5% | +3.8% | +11.8% | +14.7% |
| FCF MarginFCF ÷ Revenue | +24.2% | +5.3% | +10.9% | +17.2% | +17.3% |
| Rev. Growth (YoY)Latest quarter vs prior year | -2.4% | -3.0% | -3.3% | +0.1% | +7.4% |
| EPS Growth (YoY)Latest quarter vs prior year | -20.5% | -61.5% | +48.8% | +2.2% | +5.8% |
Valuation Metrics
ENR leads this category, winning 5 of 7 comparable metrics.
Valuation Metrics
At 5.6x trailing earnings, ENR trades at a 82% valuation discount to CHD's 31.1x P/E. Adjusting for growth (PEG ratio), ENR offers better value at 0.15x vs PG's 4.01x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $2.6B | $1.3B | $1.8B | $22.2B | $341.3B |
| Enterprise ValueMkt cap + debt − cash | $3.5B | $4.6B | $2.4B | $24.0B | $367.2B |
| Trailing P/EPrice ÷ TTM EPS | 12.72x | 5.58x | 20.37x | 31.09x | 22.44x |
| Forward P/EPrice ÷ next-FY EPS est. | 12.02x | 5.57x | 14.84x | 25.01x | 21.14x |
| PEG RatioP/E ÷ EPS growth rate | 1.40x | 0.15x | 1.57x | — | 4.01x |
| EV / EBITDAEnterprise value multiple | 9.62x | 6.99x | 10.59x | 18.14x | 15.76x |
| Price / SalesMarket cap ÷ Revenue | 2.27x | 0.43x | 0.65x | 3.59x | 4.05x |
| Price / BookPrice ÷ Book value/share | 1.49x | 7.86x | 1.07x | 5.73x | 6.86x |
| Price / FCFMarket cap ÷ FCF | 10.62x | 20.09x | 11.04x | 20.35x | 24.30x |
Profitability & Efficiency
PG leads this category, winning 4 of 9 comparable metrics.
Profitability & Efficiency
ENR delivers a 116.9% return on equity — every $100 of shareholder capital generates $117 in annual profit, vs $6 for SPB. SPB carries lower financial leverage with a 0.34x debt-to-equity ratio, signaling a more conservative balance sheet compared to ENR's 20.79x. On the Piotroski fundamental quality scale (0–9), PBH scores 8/9 vs PG's 5/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +10.2% | +116.9% | +5.5% | +17.4% | +23.8% |
| ROA (TTM)Return on assets | +5.3% | +4.4% | +3.0% | +8.2% | +10.0% |
| ROICReturn on invested capital | +9.1% | +11.8% | +3.9% | +13.9% | +20.1% |
| ROCEReturn on capital employed | +10.4% | +14.5% | +4.2% | +14.4% | +23.0% |
| Piotroski ScoreFundamental quality 0–9 | 8 | 6 | 6 | 7 | 5 |
| Debt / EquityFinancial leverage | 0.57x | 20.79x | 0.34x | 0.55x | 0.68x |
| Net DebtTotal debt minus cash | $946M | $3.3B | $531M | $1.8B | $25.9B |
| Cash & Equiv.Liquid assets | $98M | $236M | $124M | $409M | $9.6B |
| Total DebtShort + long-term debt | $1.0B | $3.5B | $654M | $2.2B | $35.5B |
| Interest CoverageEBIT ÷ Interest expense | 7.40x | 2.85x | 3.33x | 15.59x | 487.21x |
Total Returns (Dividends Reinvested)
SPB leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in PG five years ago would be worth $12,240 today (with dividends reinvested), compared to $4,857 for ENR. Over the past 12 months, SPB leads with a +30.1% total return vs PBH's -32.9%. The 3-year compound annual growth rate (CAGR) favors SPB at 4.5% vs ENR's -13.9% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | -10.8% | -5.5% | +31.7% | +14.0% | +4.5% |
| 1-Year ReturnPast 12 months | -32.9% | -9.9% | +30.1% | +3.4% | -5.6% |
| 3-Year ReturnCumulative with dividends | -8.3% | -36.3% | +14.2% | +0.7% | +1.9% |
| 5-Year ReturnCumulative with dividends | +18.4% | -51.4% | -7.8% | +13.7% | +22.4% |
| 10-Year ReturnCumulative with dividends | -3.7% | -31.3% | +11.9% | +113.6% | +119.3% |
| CAGR (3Y)Annualised 3-year return | -2.8% | -13.9% | +4.5% | +0.2% | +0.6% |
Risk & Volatility
Evenly matched — SPB and PG each lead in 1 of 2 comparable metrics.
Risk & Volatility
PG is the less volatile stock with a 0.10 beta — it tends to amplify market swings less than ENR's 1.24 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. SPB currently trades 90.4% from its 52-week high vs PBH's 61.1% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.53x | 1.24x | 0.82x | 0.14x | 0.10x |
| 52-Week HighHighest price in past year | $89.37 | $30.29 | $86.95 | $106.04 | $170.99 |
| 52-Week LowLowest price in past year | $51.24 | $16.00 | $49.99 | $81.33 | $137.62 |
| % of 52W HighCurrent price vs 52-week peak | +61.1% | +61.2% | +90.4% | +88.5% | +85.4% |
| RSI (14)Momentum oscillator 0–100 | 36.4 | 49.9 | 61.3 | 49.1 | 53.7 |
| Avg Volume (50D)Average daily shares traded | 478K | 1.1M | 318K | 1.8M | 7.2M |
Analyst Outlook
Evenly matched — ENR and PG each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: PBH as "Buy", ENR as "Hold", SPB as "Buy", CHD as "Buy", PG as "Buy". Consensus price targets imply 25.1% upside for ENR (target: $23) vs 6.1% for CHD (target: $100). For income investors, ENR offers the higher dividend yield at 6.52% vs CHD's 1.25%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Hold | Buy | Buy | Buy |
| Price TargetConsensus 12-month target | $66.00 | $23.20 | $85.00 | $99.60 | $161.88 |
| # AnalystsCovering analysts | 17 | 24 | 21 | 34 | 52 |
| Dividend YieldAnnual dividend ÷ price | — | +6.5% | +2.4% | +1.3% | +2.8% |
| Dividend StreakConsecutive years of raises | — | 2 | 1 | 23 | 36 |
| Dividend / ShareAnnual DPS | — | $1.21 | $1.86 | $1.18 | $4.02 |
| Buyback YieldShare repurchases ÷ mkt cap | +2.0% | +7.1% | +17.8% | +4.0% | +1.9% |
PBH leads in 1 of 6 categories (Income & Cash Flow). ENR leads in 1 (Valuation Metrics). 2 tied.
PBH vs ENR vs SPB vs CHD vs PG: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is PBH or ENR or SPB or CHD or PG a better buy right now?
For growth investors, Energizer Holdings, Inc.
(ENR) is the stronger pick with 2. 3% revenue growth year-over-year, versus -5. 2% for Spectrum Brands Holdings, Inc. (SPB). Energizer Holdings, Inc. (ENR) offers the better valuation at 5. 6x trailing P/E (5. 6x forward), making it the more compelling value choice. Analysts rate Prestige Consumer Healthcare Inc. (PBH) a "Buy" — based on 17 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — PBH or ENR or SPB or CHD or PG?
On trailing P/E, Energizer Holdings, Inc.
(ENR) is the cheapest at 5. 6x versus Church & Dwight Co. , Inc. at 31. 1x. On forward P/E, Energizer Holdings, Inc. is actually cheaper at 5. 6x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Energizer Holdings, Inc. wins at 0. 15x versus The Procter & Gamble Company's 3. 78x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — PBH or ENR or SPB or CHD or PG?
Over the past 5 years, The Procter & Gamble Company (PG) delivered a total return of +22.
4%, compared to -51. 4% for Energizer Holdings, Inc. (ENR). Over 10 years, the gap is even starker: PG returned +119. 3% versus ENR's -31. 3%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — PBH or ENR or SPB or CHD or PG?
By beta (market sensitivity over 5 years), The Procter & Gamble Company (PG) is the lower-risk stock at 0.
10β versus Energizer Holdings, Inc. 's 1. 24β — meaning ENR is approximately 1099% more volatile than PG relative to the S&P 500. On balance sheet safety, Spectrum Brands Holdings, Inc. (SPB) carries a lower debt/equity ratio of 34% versus 21% for Energizer Holdings, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — PBH or ENR or SPB or CHD or PG?
By revenue growth (latest reported year), Energizer Holdings, Inc.
(ENR) is pulling ahead at 2. 3% versus -5. 2% for Spectrum Brands Holdings, Inc. (SPB). On earnings-per-share growth, the picture is similar: Energizer Holdings, Inc. grew EPS 538. 5% year-over-year, compared to -5. 6% for Spectrum Brands Holdings, Inc.. Over a 3-year CAGR, CHD leads at 4. 9% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — PBH or ENR or SPB or CHD or PG?
The Procter & Gamble Company (PG) is the more profitable company, earning 19.
0% net margin versus 3. 6% for Spectrum Brands Holdings, Inc. — meaning it keeps 19. 0% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: PBH leads at 29. 6% versus 4. 4% for SPB. At the gross margin level — before operating expenses — PBH leads at 55. 8%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is PBH or ENR or SPB or CHD or PG more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Energizer Holdings, Inc. (ENR) is the more undervalued stock at a PEG of 0. 15x versus The Procter & Gamble Company's 3. 78x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Energizer Holdings, Inc. (ENR) trades at 5. 6x forward P/E versus 25. 0x for Church & Dwight Co. , Inc. — 19. 4x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for ENR: 25. 1% to $23. 20.
08Which pays a better dividend — PBH or ENR or SPB or CHD or PG?
In this comparison, ENR (6.
5% yield), PG (2. 8% yield), SPB (2. 4% yield), CHD (1. 3% yield) pay a dividend. PBH does not pay a meaningful dividend and should not be held primarily for income.
09Is PBH or ENR or SPB or CHD or PG better for a retirement portfolio?
For long-horizon retirement investors, The Procter & Gamble Company (PG) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.
10), 2. 8% yield, +119. 3% 10Y return). Both have compounded well over 10 years (PG: +119. 3%, ENR: -31. 3%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between PBH and ENR and SPB and CHD and PG?
These companies operate in different sectors (PBH (Healthcare) and ENR (Industrials) and SPB (Consumer Defensive) and CHD (Consumer Defensive) and PG (Consumer Defensive)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: PBH is a small-cap deep-value stock; ENR is a small-cap deep-value stock; SPB is a small-cap quality compounder stock; CHD is a mid-cap quality compounder stock; PG is a large-cap quality compounder stock. ENR, SPB, CHD, PG pay a dividend while PBH does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.